Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
04 Aprile 2024 - 7:00AM
Pharming Group announces the filing of its 2023 Annual Report and
Form 20-F
Leiden, The Netherlands, April 4,
2024: Pharming Group N.V. (“Pharming” or “the Company”)
(Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the filing of
its Annual Report for the year ended December 31, 2023 (the
“Period”). The Annual Report is available under Investors/Financial
documents on the Pharming.com website.
The Company also announces the filing of its
Annual Report on Form 20-F with the U.S. Securities and Exchange
Commission (SEC) for the Period. The 2023 Annual Report on Form
20-F can be found under Investors/SEC filings on Pharming.com and
through the SEC website once it has been filed.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules, biologics, and
gene therapies that are in early to late-stage development.
Pharming is headquartered in Leiden, Netherlands, and has employees
around the globe who serve patients in over 30 markets in North
America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
Inside Information
This press release relates to the disclosure of
information that qualifies, or may have qualified, as inside
information within the meaning of Article 7(1) of the EU Market
Abuse Regulation.
For further public information,
contact:
Pharming Group, Leiden, The
NetherlandsMichael Levitan, VP Investor Relations &
Corporate CommunicationsT: +1 (908) 705 1696E:
investor@pharming.com
FTI Consulting, London, UKVictoria
Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication,
Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64
27E: pharming@lifespring.nl
Grafico Azioni Pharming Group NV (TG:PHGN)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Pharming Group NV (TG:PHGN)
Storico
Da Nov 2023 a Nov 2024
